Fetal therapy with mTOR inhibitors in cardiac rhabdomyoma and lymphatic malformations

Nikan Zargarzadeh, Pegah Rashidian, Tishi Shah, Greg Ryan, Yalda Afshar

Open source

DOI
10.1016/j.bpobgyn.2025.102673
Published
2025-12
Container
Best Practice & Research Clinical Obstetrics & Gynaecology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.bpobgyn.2025.102673,
  title = {Fetal therapy with mTOR inhibitors in cardiac rhabdomyoma and lymphatic malformations},
  author = {Nikan Zargarzadeh and Pegah Rashidian and Tishi Shah and Greg Ryan and Yalda Afshar},
  year = {2025},
  journal = {Best Practice \& Research Clinical Obstetrics \& Gynaecology},
  doi = {10.1016/j.bpobgyn.2025.102673},
  url = {https://doi.org/10.1016/j.bpobgyn.2025.102673}
}

RIS

TY  - JOUR
TI  - Fetal therapy with mTOR inhibitors in cardiac rhabdomyoma and lymphatic malformations
AU  - Nikan Zargarzadeh
AU  - Pegah Rashidian
AU  - Tishi Shah
AU  - Greg Ryan
AU  - Yalda Afshar
PY  - 2025
JO  - Best Practice & Research Clinical Obstetrics & Gynaecology
DO  - 10.1016/j.bpobgyn.2025.102673
UR  - https://doi.org/10.1016/j.bpobgyn.2025.102673
ER  - 

APA

Zargarzadeh, N., Rashidian, P., Shah, T., Ryan, G., & Afshar, Y. (2025). Fetal therapy with mTOR inhibitors in cardiac rhabdomyoma and lymphatic malformations. Best Practice & Research Clinical Obstetrics & Gynaecology. https://doi.org/10.1016/j.bpobgyn.2025.102673

Source records